Title: <i>TERT</i> Promoter Mutations Were Not Found in Papillary Thyroid Microcarcinomas That Showed Disease Progression on Active Surveillance
Abstract: ThyroidVol. 27, No. 9 Letters to the EditorTERT Promoter Mutations Were Not Found in Papillary Thyroid Microcarcinomas That Showed Disease Progression on Active SurveillanceTomonori Yabuta, Michiko Matsuse, Mitsuyoshi Hirokawa, Shunichi Yamashita, Norisato Mitsutake, and Akira MiyauchiTomonori YabutaDepartment of Surgery, Kuma Hospital, Kobe, Japan.*These authors contributed equally to this work.Search for more papers by this author, Michiko MatsuseDepartment of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.*These authors contributed equally to this work.Search for more papers by this author, Mitsuyoshi HirokawaDepartment of Diagnostic Pathology, Kuma Hospital, Kobe, Japan.Search for more papers by this author, Shunichi YamashitaDepartment of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.Department of Radiation Molecular Epidemiology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.Search for more papers by this author, Norisato MitsutakeDepartment of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.Search for more papers by this author, and Akira MiyauchiDepartment of Surgery, Kuma Hospital, Kobe, Japan.Search for more papers by this authorPublished Online:1 Sep 2017https://doi.org/10.1089/thy.2016.0645AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"TERT Promoter Mutations Were Not Found in Papillary Thyroid Microcarcinomas That Showed Disease Progression on Active Surveillance." Thyroid, 27(9), pp. 1206–1207FiguresReferencesRelatedDetailsCited byConservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience13 March 2023 | Thyroid Research, Vol. 16, No. 1A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases Artur Kuchareczko, Janusz Kopczyński, Artur Kowalik, Kinga Hińcza-Nowak, Agnieszka Walczyk, Iwona Pałyga, Tomasz Trybek, Monika Szymonek, Danuta Gąsior-Perczak, Klaudia Gadawska-Juszczyk, Estera Mikina, Izabela Płachta, Agnieszka Suligowska, Agnieszka Płusa, Magdalena Chrapek, Tomasz Łopatyński, Stanisław Góźdź, and Aldona Kowalska11 November 2022 | Thyroid, Vol. 32, No. 11Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma PatientsEndocrinology and Metabolism, Vol. 37, No. 4TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma11 March 2022 | Frontiers in Endocrinology, Vol. 13Active Surveillance of Thyroid Microcarcinomas: a Critical View21 January 2022 | Current Oncology Reports, Vol. 24, No. 1Papillary thyroid microcarcinoma: Is active surveillance always enough?28 June 2021 | Clinical Endocrinology, Vol. 95, No. 6Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid MicrocarcinomaEndocrinology and Metabolism, Vol. 36, No. 4Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification2 March 2021 | Endocrine Pathology, Vol. 32, No. 1Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma Iwao Sugitani, Yasuhiro Ito, Dai Takeuchi, Hirotaka Nakayama, Chie Masaki, Hisakazu Shindo, Masanori Teshima, Kazuhiko Horiguchi, Yusaku Yoshida, Toshiharu Kanai, Mitsuyoshi Hirokawa, Kiyomi Y. Hames, Isao Tabei, and Akira Miyauchi12 February 2021 | Thyroid, Vol. 31, No. 2Papillary Carcinoma ObservationEarly Diagnosis of Low-Risk Papillary Thyroid Cancer Results Rather in Overtreatment Than a Better Survival6 October 2020 | Frontiers in Endocrinology, Vol. 11Lymphovascular invasion of papillary thyroid carcinoma revisited in the era of active surveillanceEuropean Journal of Surgical Oncology, Vol. 46, No. 10Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in KoreansJournal of Pathology and Translational Medicine, Vol. 54, No. 4Active surveillance in low risk papillary thyroid carcinomaWorld Journal of Clinical Oncology, Vol. 11, No. 6Wolf in Sheep's Clothing: Papillary Thyroid Microcarcinoma in the USJournal of the American College of Surgeons, Vol. 230, No. 4Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma15 January 2020 | Pathology International, Vol. 70, No. 4Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review6 January 2020 | Expert Review of Endocrinology & Metabolism, Vol. 15, No. 1Lenvatinib for thyroid cancer treatment: discovery, pre-clinical development and clinical application13 October 2019 | Expert Opinion on Drug Discovery, Vol. 15, No. 1Advances in the Diagnosis and Management of Papillary Thyroid MicrocarcinomaEvaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis9 April 2019 | Scientific Reports, Vol. 9, No. 1Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinionArchives of Endocrinology and MetabolismThe non-interventional approach to papillary thyroid microcarcinomas. An “active surveillance” dilemmaSurgical Oncology, Vol. 29Conservative Surveillance Management of Low-Risk Papillary Thyroid MicrocarcinomaEndocrinology and Metabolism Clinics of North America, Vol. 48, No. 1Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned9 November 2018 | Nature Reviews Clinical Oncology, Vol. 16, No. 3Active Surveillance as First-Line Management of Papillary MicrocarcinomaAnnual Review of Medicine, Vol. 70, No. 1Management of Papillary Microcarcinoma of the Thyroid with A Short Column (Management of Tumors Diagnosed as Follicular Neoplasm on Cytology)7 May 2019Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects14 December 2018 | Frontiers in Endocrinology, Vol. 9Telomere Maintenance Mechanisms in Cancer3 May 2018 | Genes, Vol. 9, No. 5 Volume 27Issue 9Sep 2017 InformationCopyright 2017, Mary Ann Liebert, Inc.To cite this article:Tomonori Yabuta, Michiko Matsuse, Mitsuyoshi Hirokawa, Shunichi Yamashita, Norisato Mitsutake, and Akira Miyauchi.TERT Promoter Mutations Were Not Found in Papillary Thyroid Microcarcinomas That Showed Disease Progression on Active Surveillance.Thyroid.Sep 2017.1206-1207.http://doi.org/10.1089/thy.2016.0645Published in Volume: 27 Issue 9: September 1, 2017Online Ahead of Print:July 11, 2017Online Ahead of Editing: June 14, 2017PDF download
Publication Year: 2017
Publication Date: 2017-09-01
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 48
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot